NM_001388492.1:c.3801C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001388492.1(HTT):c.3801C>T(p.Leu1267Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 1,552,978 control chromosomes in the GnomAD database, including 71,274 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 5646 hom., cov: 32)
Exomes 𝑓: 0.30 ( 65628 hom. )
Consequence
HTT
NM_001388492.1 synonymous
NM_001388492.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.59
Publications
23 publications found
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 4-3160329-C-T is Benign according to our data. Variant chr4-3160329-C-T is described in ClinVar as Benign. ClinVar VariationId is 1599466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.6 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.367 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.240 AC: 36523AN: 152040Hom.: 5641 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
36523
AN:
152040
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.287 AC: 45697AN: 159328 AF XY: 0.281 show subpopulations
GnomAD2 exomes
AF:
AC:
45697
AN:
159328
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.300 AC: 420467AN: 1400820Hom.: 65628 Cov.: 32 AF XY: 0.297 AC XY: 205228AN XY: 691090 show subpopulations
GnomAD4 exome
AF:
AC:
420467
AN:
1400820
Hom.:
Cov.:
32
AF XY:
AC XY:
205228
AN XY:
691090
show subpopulations
African (AFR)
AF:
AC:
1498
AN:
31992
American (AMR)
AF:
AC:
9939
AN:
35856
Ashkenazi Jewish (ASJ)
AF:
AC:
7738
AN:
25164
East Asian (EAS)
AF:
AC:
13598
AN:
36452
South Asian (SAS)
AF:
AC:
14851
AN:
79384
European-Finnish (FIN)
AF:
AC:
21194
AN:
49482
Middle Eastern (MID)
AF:
AC:
708
AN:
5700
European-Non Finnish (NFE)
AF:
AC:
334597
AN:
1078738
Other (OTH)
AF:
AC:
16344
AN:
58052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
14446
28893
43339
57786
72232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11102
22204
33306
44408
55510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.240 AC: 36530AN: 152158Hom.: 5646 Cov.: 32 AF XY: 0.243 AC XY: 18051AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
36530
AN:
152158
Hom.:
Cov.:
32
AF XY:
AC XY:
18051
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
2460
AN:
41554
American (AMR)
AF:
AC:
3846
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1086
AN:
3470
East Asian (EAS)
AF:
AC:
1965
AN:
5162
South Asian (SAS)
AF:
AC:
917
AN:
4830
European-Finnish (FIN)
AF:
AC:
4661
AN:
10574
Middle Eastern (MID)
AF:
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20861
AN:
67966
Other (OTH)
AF:
AC:
467
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1310
2621
3931
5242
6552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1057
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.